phenylguanidine has been researched along with amiloride in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, S; Davidson, D; Fesik, SW; Hajduk, PJ; Nettesheim, D; Nienaber, V; Rockway, T; Severin, J; Smith, R | 1 |
| Adriaenssens, Y; Augustyns, K; De Winter, H; Gladysz, R; Joossens, J; Lambeir, AM; Van der Veken, P | 1 |
| Davidson, D; Henkin, J; Nienaber, V; Wang, J | 1 |
| Arroyo de Prada, N; Graeff, H; Luther, T; Magdolen, U; Magdolen, V; Muehlenweg, B; Reuning, U; Schmitt, M; Sperl, S; Wilhelm, OG | 1 |
1 review(s) available for phenylguanidine and amiloride
| Article | Year |
|---|---|
Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator.
Topics: Amidines; Amiloride; Animals; Benzamidines; Guanidines; Mice; Mice, Knockout; Models, Biological; Molecular Structure; Neoplasm Invasiveness; Neoplasm Proteins; Phenotype; Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Serine Proteinase Inhibitors; Serpins; Structure-Activity Relationship; Thiophenes; Urokinase-Type Plasminogen Activator | 2000 |
3 other study(ies) available for phenylguanidine and amiloride
| Article | Year |
|---|---|
Identification of novel inhibitors of urokinase via NMR-based screening.
Topics: Benzimidazoles; Crystallography, X-Ray; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Models, Molecular; Structure-Activity Relationship; Urokinase-Type Plasminogen Activator | 2000 |
Discovery and SAR of Novel and Selective Inhibitors of Urokinase Plasminogen Activator (uPA) with an Imidazo[1,2-a]pyridine Scaffold.
Topics: Catalytic Domain; Drug Design; Enzyme Inhibitors; Humans; Imidazoles; Molecular Docking Simulation; Pyridines; Structure-Activity Relationship; Urokinase-Type Plasminogen Activator | 2015 |
Re-engineering of human urokinase provides a system for structure-based drug design at high resolution and reveals a novel structural subsite.
Topics: Amiloride; Binding Sites; Crystallization; Drug Design; Guanidines; Humans; Molecular Weight; Protein Engineering; Urokinase-Type Plasminogen Activator | 2000 |